| Oct 29 |
Biogen, Neomorph to collaborate on clinical candidates for Alzheimer's
|
| Oct 29 |
Biogen and Neomorph Announce Multi-Target Research Collaboration to Discover and Develop Molecular Glue Degraders for Alzheimer’s, Rare, and Immunological Diseases
|
| Oct 29 |
Eli Lilly Q3 earnings expected to beat Wall Street expectations
|
| Oct 29 |
Biogen Q3 2024 Earnings Preview
|
| Oct 29 |
Biogen names former Bristol-Myers executive as medical chief
|
| Oct 29 |
Biogen Appoints Daniel Quirk, MD, as Chief Medical Officer
|
| Oct 29 |
Biogen refreshes its C-suite; Novartis writes down MorphoSys assets
|
| Oct 28 |
Seeking Clues to Biogen (BIIB) Q3 Earnings? A Peek Into Wall Street Projections for Key Metrics
|
| Oct 28 |
Biogen's CFO Michael McDonnell to retire in February 2025
|
| Oct 28 |
Michael McDonnell, Executive Vice President and Chief Financial Officer to Retire in February 2025
|
